Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Nature Reviews Drug Discovery 21, 329 (2022)
Updates & Corrections
Correction 20 April 2022: Suvorexant and and lemborexant were described as orexin receptor agonists rather than antagonists, and this has been corrected.
The author declares no competing interests.